Dear Prof CERASALE MORTEO,
I’m happy to announce Applied Cancer Research has launched and would like share some recent article highlights with you. Alongside these articles, I invite you to submit your next manuscript to our open access journal.
Please see our submission guidelines to find out about how our 3-step process makes submitting your manuscript as simple as possible.
I’m happy to announce Applied Cancer Research has launched and would like share some recent article highlights with you. Alongside these articles, I invite you to submit your next manuscript to our open access journal.
Please see our submission guidelines to find out about how our 3-step process makes submitting your manuscript as simple as possible.
Featured Articles
| RESEARCH | ||||
| Quality assurance and patient safety protocols for breast and gynecologic pathology in an Academic Women’s Hospital | ||||
 |
| |||
| REVIEW | ||||
| What is new in Genitourinary Pathology? Recent developments and highlights of the new 2016 World Health Organization classification of tumors of the urinary system and male genital organs | ||||
 |
| |||
| RESEARCH | ||||
| RUNX2 and WWOX genes as molecular biomarkers and candidates for targeted therapy in Egyptian patients with primary conventional osteosarcoma | ||||
 |
| |||
Journal Scope
Applied Cancer Research is an open access, peer-reviewed journal focused on clinical, surgical and translational research in the field of oncology. The journal considers for publication original articles addressing genetics, pathology, diagnosis, treatment, patient care, and epidemiology.
As a multidisciplinary journal, Applied Cancer Research aims to be a forum for exchanging relevant information among researchers, health care practitioners and health policy makers, helping them enhance prevention and decrease mortality rates from malignant diseases, improve the management of patients afflicted by them and the quality of life of people during and after treatment.
As a multidisciplinary journal, Applied Cancer Research aims to be a forum for exchanging relevant information among researchers, health care practitioners and health policy makers, helping them enhance prevention and decrease mortality rates from malignant diseases, improve the management of patients afflicted by them and the quality of life of people during and after treatment.
Reasons to Publish with Us
| • | All articles are open access: universally accessible online without charge |
| • | No page restrictions and ability to support data and video files |
| • | The official journal of AC Camargo Cancer Center |
Register to receive the latest articles, straight to your inbox.
Best wishes,
José Vassallo
Editor-in-Chief
José Vassallo
Editor-in-Chief
SOCIETY AFFILIATION
Affiliated with the A. C. Camargo Cancer Center
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.
No hay comentarios:
Publicar un comentario